Health Catalyst will release Q3 2025 results on November 10, 2025, followed by a conference call at 5:00 pm ET.
Quiver AI Summary
Health Catalyst, Inc. will release its third quarter 2025 operating results on November 10, 2025, following market close, and will hold a conference call at 5:00 pm ET to discuss the results. Participants can join the call by dialing specific numbers or through a live audio webcast available on the company's investor relations website. A replay of the call will be accessible shortly after its conclusion. Health Catalyst is a prominent provider of data and analytics solutions for healthcare organizations, serving over 1,100 clients worldwide with tools designed to enhance clinical, financial, and operational outcomes.
Potential Positives
- Announcement of third quarter 2025 operating results scheduled for November 10, 2025, indicating transparency and regular communication with investors.
- Host of a conference call to discuss the operating results, providing an opportunity for direct engagement with investors and analysts.
- Health Catalyst emphasizes its role as a leading provider of data and analytics technology, showcasing a strong market position with over 1,100 organizations relying on its services.
- Company highlights its proven track record of delivering measurable results, reinforcing investor confidence in its capability to drive healthcare improvements.
Potential Negatives
- Health Catalyst's upcoming earnings report may be viewed with concern due to potential volatility in stock prices following the release of financial results, particularly if they do not meet market expectations.
- The timing of the earnings call, after market close, may limit immediate investor feedback and reaction, potentially affecting trading when the market opens the following day.
- The reliance on a specific technology ecosystem and solutions could raise questions about the long-term sustainability and competitive advantages of Health Catalyst's offerings in a rapidly evolving healthcare data landscape.
FAQ
When will Health Catalyst release its Q3 2025 results?
Health Catalyst will release its third quarter 2025 operating results on November 10, 2025, after market close.
How can I listen to the Health Catalyst conference call?
You can access the conference call by dialing 800-343-5172 for U.S. participants or 203-518-9856 for international participants.
What time is the Health Catalyst conference call scheduled?
The conference call is scheduled for 5:00 pm ET on November 10, 2025.
Where can I find the webcast of the conference call?
The live audio webcast will be available at https://ir.healthcatalyst.com/.
How long will the conference call replay be available?
The replay of the conference call will be available for approximately 90 days after the call.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$HCAT Insider Trading Activity
$HCAT insiders have traded $HCAT stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $HCAT stock by insiders over the last 6 months:
- BENJAMIN LANDRY (General Counsel) has made 0 purchases and 2 sales selling 12,232 shares for an estimated $44,595.
- DANIEL LESUEUR (Chief Operating Officer) sold 5,209 shares for an estimated $21,331
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$HCAT Hedge Fund Activity
We have seen 68 institutional investors add shares of $HCAT stock to their portfolio, and 79 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP removed 2,085,392 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $7,861,927
- WHETSTONE CAPITAL ADVISORS, LLC added 2,026,278 shares (+118.8%) to their portfolio in Q2 2025, for an estimated $7,639,068
- FIRST LIGHT ASSET MANAGEMENT, LLC added 1,793,374 shares (+17.2%) to their portfolio in Q2 2025, for an estimated $6,761,019
- PORTOLAN CAPITAL MANAGEMENT, LLC added 663,330 shares (+50.4%) to their portfolio in Q2 2025, for an estimated $2,500,754
- NUVEEN, LLC removed 466,725 shares (-79.1%) from their portfolio in Q2 2025, for an estimated $1,759,553
- MILLENNIUM MANAGEMENT LLC removed 437,255 shares (-87.8%) from their portfolio in Q2 2025, for an estimated $1,648,451
- CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. added 372,035 shares (+53.6%) to their portfolio in Q2 2025, for an estimated $1,402,571
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$HCAT Analyst Ratings
Wall Street analysts have issued reports on $HCAT in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Keybanc issued a "Overweight" rating on 10/08/2025
- Canaccord Genuity issued a "Buy" rating on 08/29/2025
- Wells Fargo issued a "Overweight" rating on 08/11/2025
To track analyst ratings and price targets for $HCAT, check out Quiver Quantitative's $HCAT forecast page.
$HCAT Price Targets
Multiple analysts have issued price targets for $HCAT recently. We have seen 8 analysts offer price targets for $HCAT in the last 6 months, with a median target of $4.0.
Here are some recent targets:
- Elizabeth Anderson from Evercore ISI Group set a target price of $3.0 on 10/08/2025
- Scott Schoenhaus from Keybanc set a target price of $4.0 on 10/08/2025
- Sarah James from Cantor Fitzgerald set a target price of $4.0 on 10/07/2025
- Richard Close from Canaccord Genuity set a target price of $5.0 on 08/29/2025
- Jessica Tassan from Piper Sandler set a target price of $4.0 on 08/27/2025
- Stan Berenshteyn from Wells Fargo set a target price of $6.0 on 08/11/2025
- David Grossman from Stifel set a target price of $4.5 on 08/08/2025
Full Release
SALT LAKE CITY, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its third quarter 2025 operating results on Monday, November 10, 2025, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day.
Conference Call Details
The conference call can be accessed by dialing 800-343-5172 for U.S. participants, or 203-518-9856 for international participants, and referencing conference ID “HCATQ325.” A live audio webcast will be available online at https://ir.healthcatalyst.com/ . A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.
About Health Catalyst
Health Catalyst (Nasdaq: HCAT) is a leading provider of data and analytics technology and services that ignite smarter healthcare, lighting the path to measurable clinical, financial, and operational improvement. More than 1,100 organizations worldwide rely on Health Catalyst's offerings, including our cloud-based technology ecosystem Health Catalyst Ignite™, AI-enabled data and analytics solutions, and expert services to drive meaningful outcomes across hundreds of millions of patient records. Powered by high-value data, standardized measures and registries, and deep healthcare domain expertise, Ignite helps organizations transform complex information into actionable insights. Backed by a multi-decade mission and a proven track record of delivering billions of dollars in measurable results, Health Catalyst continues to serve as the catalyst for massive, measurable, data-informed healthcare improvement and innovation.
Health Catalyst Investor Relations Contact:
Matt Hopper
SVP of Finance and Head of Investor Relations
Phone: 855-309-6800
[email protected]
Health Catalyst Media Contact:
Kathryn Mykleseth
Director of Public Relations and Communications
[email protected]
